1.
Reticulocyte Preference and Stage Development of Plasmodium vivax Isolates
by Lim, Caeul
The Journal of Infectious Diseases, 2016, Vol. 214(7), pp.1081-1084
2.
Source of homologous parasites in recurrent Plasmodium vivax malaria.
by Markus, Miles B
The Journal of infectious diseases, August 15, 2012, Vol.206(4), pp.622-623
3.
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial
by Phyo, Aung Pyae
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, November 2011, Vol.53(10), pp.977-84
4.
5.
Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse
by Lin, Jessica T
The Journal of Infectious Diseases, 2015, Vol. 212(6), pp.999-1008
6.
Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers.
by Mccarthy, James S
The Journal of infectious diseases, November 15, 2013, Vol.208(10), pp.1688-1694
7.
Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax.
by Gruszczyk, Jakub
Science (New York, N.Y.), January 5, 2018, Vol.359(6371), pp.48-55
8.
The biology of Plasmodium vivax explored through genomics
by Luo, Zunping
Annals of the New York Academy of Sciences, April 2015, Vol.13421(1), pp.53-61
9.
Paucity of Plasmodium vivax mature schizonts in peripheral blood is associated with their increased cytoadhesive potential.
by Lopes, Stefanie C P
The Journal of infectious diseases, May 1, 2014, Vol.209(9), pp.1403-1407
10.
Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement
by Gruszczyk, Jakub
Proceedings of the National Academy of Sciences of the United States of America, 12 January 2016, Vol.113(2), pp.E191-200
11.
Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.
by Chen, Edwin
Proceedings of the National Academy of Sciences of the United States of America, May 31, 2016, Vol.113(22), pp.6277-6282
12.
Plasmodium vivax Seroprevalence in Bred Cynomolgus Monkeys, China
by Elmore, David B
Emerging infectious diseases, October 2011, Vol.17(10), pp.1978-9
13.
14.
15.
The changing epidemiology of malaria elimination: new strategies for new challenges.
by Cotter, Chris
Lancet (London, England), September 7, 2013, Vol.382(9895), pp.900-911
16.
Plasmodium vivax Sub-Patent Infections after Radical Treatment Are Common in Peruvian Patients: Results of a 1-Year Prospective Cohort Study
by Van Den Eede, Peter
PLoS ONE, January 28, 2011, Vol.6(1)
17.
Immunity to malaria in Plasmodium vivax infection: a study in central China.
by Jangpatarapongsa, Kulachart
PloS one, 2012, Vol.7(9), p.e45971
18.
Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure.
by Diez Benavente, Ernest
PloS one, 2017, Vol.12(5), p.e0177134
19.
20.
Plasmodium vivax sporozoite challenge in malaria-naïve and semi-immune Colombian volunteers.
by Arévalo-Herrera, Myriam
PloS one, 2014, Vol.9(6), p.e99754
